Seattle, WA, United States of America

Gregory C Ireton

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Gregory C Ireton: Innovator in Immunogenic Compositions

Introduction

Gregory C Ireton is a notable inventor based in Seattle, WA, with a focus on immunogenic compositions. He holds a total of five patents, showcasing his contributions to the field of biotechnology and infectious disease research. His work has significant implications for the treatment and prevention of tuberculosis infections.

Latest Patents

Among his latest patents, Ireton has developed immunogenic compositions comprising polypeptides and fusions thereof. These inventions relate to compositions and fusion proteins containing at least two specific antigens, along with polynucleotides encoding such compositions and fusion proteins. The methods associated with these inventions aim to enhance the treatment, prevention, and diagnosis of tuberculosis infections.

Career Highlights

Throughout his career, Gregory C Ireton has worked with prominent organizations such as the Infectious Disease Research Institute and Access to Advanced Health Institute. His experience in these institutions has allowed him to advance his research and contribute to significant innovations in the field.

Collaborations

Ireton has collaborated with esteemed colleagues, including Steven G Reed and Rhea N Coler. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in immunology.

Conclusion

Gregory C Ireton's work in immunogenic compositions has made a substantial impact on the field of infectious disease research. His patents and collaborations reflect his commitment to advancing medical science and improving public health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…